You have 9 free searches left this month | for more free features.

Ebola Vaccine

Showing 1 - 25 of 8,330

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ebola Virus Disease Trial in Decatur (Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV?G-ZEBOV-GP))

Not yet recruiting
  • Ebola Virus Disease
  • Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP)
  • Decatur, Georgia
    The Hope Clinic of the Emory Vaccine Center
Oct 20, 2023

Host Genetic Factors Underlying Ebola Virus Disease Risk,

Completed
  • Ebola Virus Disease
    • Kalkata, Liberia
    • +3 more
    Aug 18, 2022

    Healthy Trial in Cuangugu, Gysenyi, Kigali (Ad26.ZEBOV, MVA-BN-Filo)

    Active, not recruiting
    • Healthy
    • Ad26.ZEBOV
    • MVA-BN-Filo
    • Cuangugu, Rwanda
    • +2 more
    Jan 17, 2023

    Ebola Virus Disease Trial in Kenema (rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO))

    Not yet recruiting
    • Ebola Virus Disease
    • rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO)
    • Kenema, Eastern, Sierra Leone
      Kenema Government Hospital
    Aug 7, 2023

    Healthy Volunteers Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (rVSV-Zebov GP vaccine)

    Active, not recruiting
    • Healthy Volunteers
    • rVSV-Zebov GP vaccine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 7, 2023

    Ebola Virus Trial in Kampala (cAd3-EBO S vaccine)

    Completed
    • Ebola Virus
    • cAd3-EBO S vaccine
    • Kampala, Uganda
      Makerere University-Walter Reed Project
    Nov 10, 2022

    Ebola Virus Disease Trial in Goma, Kinshasa (Zabdeno® booster, Ervebo® booster)

    Not yet recruiting
    • Ebola Virus Disease
    • Zabdeno® booster
    • Ervebo® booster
    • Goma, Congo, The Democratic Republic of the
    • +1 more
    Nov 6, 2023

    Ebola Vaccine Trial (ERVEBO® (rVSV?G-ZEBOV-GP))

    Not yet recruiting
    • Ebola Vaccine
    • ERVEBO® (rVSV∆G-ZEBOV-GP)
    • (no location specified)
    Jul 17, 2023

    Ebola Virus Disease Trial in Kinshasa (Ad26.ZEBOV, MVA-BN-Filo vaccine)

    Active, not recruiting
    • Ebola Virus Disease
    • Ad26.ZEBOV, MVA-BN-Filo vaccine
    • Kinshasa, Congo, The Democratic Republic of the
      L'Institut National de Recherche Biomédicale RDC
    Nov 15, 2021

    Sudan Ebola Virus Vaccines Trial (CAd3, ChAdox1, rVSV-SUDV)

    Not yet recruiting
    • Sudan Ebola Virus Vaccines
    • CAd3
    • +3 more
    • (no location specified)
    Jun 8, 2023

    Ebola Virus Disease Trial in Boende (Ad26.ZEBOV vaccine)

    Completed
    • Ebola Virus Disease
    • Ad26.ZEBOV vaccine
    • Boende, Province De La Tshuapa, Congo, The Democratic Republic of the
      Hôpital Général de Référence de Boende
    Jan 3, 2023

    Ebola Trial in Oxford (ChAdOx1 biEBOV)

    Recruiting
    • Ebola
    • ChAdOx1 biEBOV
    • Oxford, United Kingdom
      Centre for Clinical Vaccinology and Tropical Medicine, Churchill
    Aug 10, 2022

    Ebola Trial in Bagamoyo (ChAdOx1 biEBOV)

    Recruiting
    • Ebola
    • ChAdOx1 biEBOV
    • Bagamoyo, Tanzania
      Bagamoyo Clinical Trial Facility
    May 17, 2022

    Vaccine-induced Immunity Against Ebola in Previously Vaccinated

    Recruiting
    • Immune Response
      • Goma, Congo, The Democratic Republic of the
      • +1 more
      May 18, 2022

      Ebola Sudan Virus Disease Trial in Siaya, Kampala (cAD3-Sudan Ebolavirus Vaccine, Placebo)

      Not yet recruiting
      • Ebola Sudan Virus Disease
      • cAD3-Sudan Ebolavirus Vaccine
      • Placebo
      • Siaya, Kenya
      • +1 more
      Sep 7, 2023

      Ebola Sudan Virus Disease Trial (rVSV?G-SEBOV-GP Vaccine or Placebo)

      Not yet recruiting
      • Ebola Sudan Virus Disease
      • rVSV∆G-SEBOV-GP Vaccine or Placebo
      • (no location specified)
      Feb 10, 2023

      Ebola Virus Disease Trial in N'Zerekore (ansuvimab, Ervebo)

      Not yet recruiting
      • Ebola Virus Disease
      • N'Zerekore, Guinea
        Centre de Traitement Ebola de N'Zerekore
      Oct 14, 2021

      Ebola Virus Disease Trial in Lambarene (rVSV?G-ZEBOV-GP, V920)

      Recruiting
      • Ebola Virus Disease
      • rVSVΔG-ZEBOV-GP, V920
      • Lambarene, Moyen-Ogooué, Gabon
        Centre de Recherches Médicales de Lambaréné
      Nov 18, 2021

      Ebola Virus Disease Trial in Entebbe (Ad26.ZEBOV/MVA-BN-Filo)

      Completed
      • Ebola Virus Disease
      • Entebbe, Uganda
        MRC/UVRI & LSHTM Uganda Research Unit
      May 10, 2021

      Ebola Trial in Brisbane, Melbourne, Nedlands (Base Dose EBOV GP Vaccine, 2x Base Dose EBOV GP Vaccine, 4x Base Dose EBOV GP

      Completed
      • Ebola
      • Base Dose EBOV GP Vaccine
      • +5 more
      • Brisbane, Queensland, Australia
      • +2 more
      Nov 23, 2021

      Ebola Disease, Immunisation Trial in Cincinnati (ChAd3-EBO-Z, MVA Multi-Filo Ebola Vaccine, Placebo)

      Completed
      • Ebola Disease
      • Immunisation
      • ChAd3-EBO-Z
      • +2 more
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center - Infectious Disea
      May 6, 2021

      Ebola Virus Disease, Ebola, Hiv Trial in Nairobi, Masaka (Ad26.ZEBOV)

      Active, not recruiting
      • Ebola Virus Disease
      • +2 more
      • Ad26.ZEBOV
      • Nairobi, Kenya
      • +1 more
      Nov 26, 2021

      Ebola Virus Disease Trial in Baltimore (HPIV3/?HNF/EbovZ GP vaccine, Placebo)

      Suspended
      • Ebola Virus Disease
      • HPIV3/ΔHNF/EbovZ GP vaccine
      • Placebo
      • Baltimore, Maryland
      • +1 more
      Mar 2, 2022

      Ebola Disease, Marburg Disease Trial in Atlanta (Ad26 Zaire Ebola Vaccine, MVA Multi-Filo Ebola Vaccine)

      Completed
      • Ebola Disease
      • Marburg Disease
      • Ad26 Zaire Ebola Vaccine
      • MVA Multi-Filo Ebola Vaccine
      • Atlanta, Georgia
        Emory Children's Center - Pediatric Infectious Diseases
      Feb 18, 2021

      Ebola Virus Disease Trial in Kambia (Ad26.ZEBOV booster vaccination, given at a dose of 5x10^10 vp, via IM injection)

      Active, not recruiting
      • Ebola Virus Disease
      • Ad26.ZEBOV booster vaccination, given at a dose of 5x10^10 vp, via IM injection
      • Kambia, Sierra Leone
        EBOVAC Kambia 1 clinic
      Feb 25, 2022